These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 18851976)
21. ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists. Bornstein B; Gottfried Y; Edison N; Shekhtman A; Lev T; Glaser F; Larisch S Apoptosis; 2011 Sep; 16(9):869-81. PubMed ID: 21695558 [TBL] [Abstract][Full Text] [Related]
22. Structural and biophysical characterization of XIAP BIR3 G306E mutant: insights in protein dynamics and application for fragment-based drug design. Moore CD; Wu H; Bolaños B; Bergqvist S; Brooun A; Pauly T; Nowlin D Chem Biol Drug Des; 2009 Sep; 74(3):212-23. PubMed ID: 19660030 [TBL] [Abstract][Full Text] [Related]
23. A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein. Potenza D; Belvisi L; Vasile F; Moroni E; Cossu F; Seneci P Org Biomol Chem; 2012 Apr; 10(16):3278-87. PubMed ID: 22407164 [TBL] [Abstract][Full Text] [Related]
24. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs. Verhagen AM; Kratina TK; Hawkins CJ; Silke J; Ekert PG; Vaux DL Cell Death Differ; 2007 Feb; 14(2):348-57. PubMed ID: 16794601 [TBL] [Abstract][Full Text] [Related]
25. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2. Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220 [TBL] [Abstract][Full Text] [Related]
26. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac. Huang Y; Rich RL; Myszka DG; Wu H J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414 [TBL] [Abstract][Full Text] [Related]
27. Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia. Saito A; Hayashi T; Okuno S; Ferrand-Drake M; Chan PH J Cereb Blood Flow Metab; 2003 Sep; 23(9):1010-9. PubMed ID: 12973017 [TBL] [Abstract][Full Text] [Related]
28. Regulation of XIAP and Smac/DIABLO in the rat hippocampus following transient forebrain ischemia. Siegelin MD; Kossatz LS; Winckler J; Rami A Neurochem Int; 2005 Jan; 46(1):41-51. PubMed ID: 15567514 [TBL] [Abstract][Full Text] [Related]
29. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists. Elsawy MA; Martin L; Tikhonova IG; Walker B Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811 [TBL] [Abstract][Full Text] [Related]
30. [The expression of Smac and XIAP in rat hippocampus following limbic seizure induced by kainic acid injection into amygdaloid nucleus]. Li TF; Luo YM; Lu CZ Sheng Li Xue Bao; 2004 Apr; 56(2):172-7. PubMed ID: 15127126 [TBL] [Abstract][Full Text] [Related]
31. Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. Fu J; Jin Y; Arend LJ J Biol Chem; 2003 Dec; 278(52):52660-72. PubMed ID: 14523016 [TBL] [Abstract][Full Text] [Related]
32. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Sun C; Cai M; Gunasekera AH; Meadows RP; Wang H; Chen J; Zhang H; Wu W; Xu N; Ng SC; Fesik SW Nature; 1999 Oct; 401(6755):818-22. PubMed ID: 10548111 [TBL] [Abstract][Full Text] [Related]
33. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454 [TBL] [Abstract][Full Text] [Related]
34. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. Deveraux QL; Leo E; Stennicke HR; Welsh K; Salvesen GS; Reed JC EMBO J; 1999 Oct; 18(19):5242-51. PubMed ID: 10508158 [TBL] [Abstract][Full Text] [Related]
35. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Huang Y; Park YC; Rich RL; Segal D; Myszka DG; Wu H Cell; 2001 Mar; 104(5):781-90. PubMed ID: 11257231 [TBL] [Abstract][Full Text] [Related]
36. Design of small-molecule Smac mimetics as IAP antagonists. Wang S Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626 [TBL] [Abstract][Full Text] [Related]
37. Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes. Paulsen M; Ussat S; Jakob M; Scherer G; Lepenies I; Schütze S; Kabelitz D; Adam-Klages S Eur J Immunol; 2008 Jul; 38(7):1979-87. PubMed ID: 18521960 [TBL] [Abstract][Full Text] [Related]
38. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493 [TBL] [Abstract][Full Text] [Related]
39. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs. Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105 [TBL] [Abstract][Full Text] [Related]
40. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. Gao Z; Tian Y; Wang J; Yin Q; Wu H; Li YM; Jiang X J Biol Chem; 2007 Oct; 282(42):30718-27. PubMed ID: 17724022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]